Executive Director, Quantitative Clinical Pharmacology
Takeda Pharmaceutical Company Limited
Neeraj Gupta, PhD, FCP, is Oncology TA head in Quantitative Clinical Pharmacology group at Takeda Pharmaceuticals. He has prospectively applied model-based approaches throughout the lifecycle of development of various drugs including NINLARO® and ALUNBRIG® resulting in an efficient clinical development plan, model-informed decision-making, optimal dose selection and model-informed elements of prescribing guidance. He was part of ASCPT Scientific Programming Committee (SPC) from 2017-2019. He has co-chaired sessions and presented at various ASCPT, ACCP Annual Meetings. He has served as an invited speaker in many national and international meetings. He is a recipient of Tanabe Young Investigator award. He is a nominated fellow of the American College of Clinical Pharmacology (ACCP). Neeraj has over 50 manuscripts and has presented over 95 abstracts at various scientific meetings. He is currently serving on 2019-2020 ACCP membership committee and is vice- chair of ASCPT Pharmacometrics & Pharmacokinetics (PMK) community.